Insulin Degludec Coupons & Savings Card – Discount Prices from $104.15
Generic for: Tresiba flextouch, Tresiba
My prescription
Edit
10ML of 100UNIT/ML, Insulin Degludec (1 Vial)
Select pharmacy
CVS
$141.74
COUPON PRICE
Walmart
$104.15
COUPON PRICE
Walgreens
$115.14
COUPON PRICE
Rite Aid
$125.42
COUPON PRICE
Albertsons
$128.83
COUPON PRICEInsulin Degludec savings card
Show this card to your pharmacistWalmart
$104.15
BIN
ID
PCN
GRP
019876
LH0FCA4B2D
CHIPPO
LHX
Powered by
More prescriptions for diabetes type 2
More prescriptions for diabetes type 2
Price history for Tresiba Flextouch (brand) & Insulin Degludec (generic)
1, 10ML of 100UNIT/ML
Average retail price for Tresiba Flextouch
Average retail price for Insulin Degludec
Average SaveHealth price for Insulin Degludec
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
We analyzed Insulin Degludec prices for (10ML of 100UNIT/ML, 1 Vial) over the last 12 months. The average retail price was $245.80, while the average price using the SaveHealth discount card was $156.38. That's a savings of approximately 36.38% when using our Insulin Degludec coupon.
Compared to the generic version, Tresiba Flextouch had an average price of $437.06 over the same time period. With the SaveHealth savings card, Insulin Degludec is 64.22% cheaper on average than Tresiba Flextouch.
Insulin Degludec dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10ML of 100UNIT/ML | 1 Vial | $104.15 | $104.15 |
Insulin Degludec Warnings
The safety and warning information for insulin degludec (Tresiba) is crucial for ensuring its safe use. Please read the following points carefully and consult your healthcare provider if you have any questions or concerns:
Infection Risk from Pen Sharing: Do not share insulin degludec (Tresiba) pens, syringes, or needles with others. Sharing can lead to severe infections and other health risks for both parties.
Blood Sugar Level Fluctuations: Altering your insulin regimen, including the injection site, can impact insulin efficacy, potentially causing high or low blood sugar. Injecting into areas with lipodystrophy, such as pitted or thickened skin, may elevate blood sugar levels.
Hypoglycemia (Low Blood Sugar): Using insulin degludec (Tresiba) alone or with other blood-sugar-lowering medications can result in dangerously low blood sugar levels, which can be life-threatening if untreated. Factors that increase this risk include dietary and exercise changes, alcohol consumption, concurrent diabetes medications, and liver or kidney issues.
Hypokalemia (Low Potassium Levels): Insulin degludec (Tresiba) can decrease blood potassium levels, posing a risk when taken with potassium-lowering medications like certain diuretics. Regular monitoring of potassium levels may be necessary.
Fluid Retention and Heart Failure Risk: Combining insulin degludec (Tresiba) with glitazones, such as pioglitazone (Actos), may lead to fluid retention, exacerbating heart failure symptoms. This risk is higher in individuals with a history of heart failure.
Allergic Reactions: Though rare, serious allergic reactions, including anaphylaxis, can occur. Seek immediate medical attention if you experience symptoms like swelling of the lips, face, or tongue; rash; or difficulty breathing.
Contraindications:
- Insulin degludec (Tresiba) should not be used during episodes of hypoglycemia (low blood sugar), as it can pose serious health risks. Always consult your healthcare provider before using this medication under such conditions.
Insulin Degludec Side Effects
Common side effects:
- Low blood sugar levels
- Common cold symptoms
- Upper respiratory tract infections
- Headaches
- Diarrhea
- Sinus infections
- Stomach viral infections
- Injection site reactions (redness, swelling, or itching)
- Weight gain
Fluid buildup
Serious side effects:
- Severely low blood sugar
- Dangerously low potassium levels
- Severe allergic reactions (rash, hives, swelling of the face, tongue, or throat, difficulty breathing)
Insulin Degludec Interactions
Is insulin degludec the same as Lantus?
Insulin degludec and Lantus are not the same. Insulin degludec is a long-acting insulin marketed under the brand name Tresiba, while Lantus is the brand name for insulin glargine, another long-acting insulin. Both are used to manage blood sugar levels in individuals with diabetes, but they have different formulations and durations of action.
Is insulin degludec available in generic?
As of the latest information, insulin degludec is not available in a generic form. It is marketed under the brand name Tresiba.
What is a cheaper alternative to Tresiba?
A potential cheaper alternative to Tresiba (insulin degludec) could be other long-acting insulins such as insulin glargine (Lantus or its biosimilar Basaglar) or insulin detemir (Levemir). However, the choice of insulin should be made in consultation with a healthcare provider, as individual needs and responses to insulin can vary. Additionally, insurance coverage and available discounts may influence the cost-effectiveness of these alternatives.
How much is insulin degludec without insurance?
The cost of insulin degludec without insurance can vary significantly depending on the pharmacy and location. On average, the price for a 10 mL vial can range from $300 to $400. It's advisable for individuals to check with local pharmacies for the most accurate pricing and explore any available discount programs or manufacturer coupons that might help reduce the cost.
What is the difference between Tresiba and degludec?
Tresiba and degludec refer to the same insulin product. Tresiba is the brand name, while insulin degludec is the generic name. Both are long-acting insulins used to manage blood sugar levels in individuals with diabetes.